4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000950170-25-110254
Director sold 19,500,000 shares at an average $0.01 ($229,172)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Behbahani Ali Director | 2025-08-15 | Sale | −4,828,206 | $0.01 | $53,110 | 14,671,794 | I |
| Behbahani Ali Director | 2025-08-18 | Sale | −14,671,794 | $0.01 | $176,062 | 0 | I |
| Open-market sales · 19,500,000 sh · avg $0.01 · $229,172 | |||||||
Loading xslF345X05/ownership.xml…